Belt and Road Summit 2025- Deal-making

10–16 Sept 2025 | China (Hong Kong)

Daejoong Life Science

www.djin.co.krSeoul, South Korea
2 profile visits

About

As a venture creation company, Daejoong Life Science set up a NewCo who would like to acquire the commercialization right of dosing completed US phase Ⅲ asset in the Great China region (China, Taiwan, Hong Kong & Macau)

Technology

Bio-TechHealth TechnologyMedical Technology

Additional questions

Other Place of Business

Hong KongMainland China East Asia

Representatives

Seungtaek NA

Managing Partner

Daejoong Life Science